Publications by authors named "Thomas Cartwright"

Claim this Profile
R
Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma.
W Quinn O'Neill, Xiujie Xie, Shanying Gui, Heping Yu, Jacqueline Davenport, Thomas Cartwright

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study.
Ian Chau, Marwan Fakih, Pilar García-Alfonso, Zdenĕk Linke, Ana Ruiz Casado, Thomas Cartwright

Cancers (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting.
Thomas H Cartwright, Monika Parisi, Janet L Espirito, Thomas W Wilson, Corey Pelletier

Drugs Real World Outcomes· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.
Bradley J Monk, Philip E Lammers, Thomas Cartwright, Ira Jacobs

Pharmaceuticals (Basel)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care.
Tawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, Fred Schreiber, Richard H Brown, Thomas H Cartwright

J Oncol Pract· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval.
Paul B Jacobsen, Ji-Hyun Lee, William Fulp, Erin M Siegel, David Shibata, Thomas Cartwright

J Oncol Pract· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Hans-Joachim Schmoll, Chris Twelves, Weijing Sun, Michael J O'Connell, Thomas Cartwright

Lancet Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Florida Initiative for Quality Cancer Care: improvements in breast cancer quality indicators during a 3-year interval.
Christine Laronga, Jhanelle E Gray, Erin M Siegel, Ji-Hyun Lee, William J Fulp, Thomas Cartwright

J Am Coll Surg· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the care of non-small-cell lung cancer after audit and feedback: the Florida initiative for quality cancer care.
Tawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, Fred Schreiber, Richard H Brown, Thomas H Cartwright

J Oncol Pract· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Florida Initiative for Quality Cancer Care: improvements on colorectal cancer quality of care indicators during a 3-year interval.
Erin M Siegel, Paul B Jacobsen, Ji-Hyun Lee, Mokenge Malafa, William Fulp, Thomas Cartwright

J Am Coll Surg· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
Jeffrey R Infante, Tony R Reid, Allen L Cohn, William J Edenfield, Terrence P Cescon, Thomas H Cartwright

Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events associated with antiangiogenic agents in combination with cytotoxic chemotherapy in metastatic colorectal cancer and their management.
Thomas H Cartwright

Clin Colorectal Cancer· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).
Herbert Hurwitz, Edith P Mitchell, Thomas Cartwright, Ambrose Kwok, Sylvia Hu

Oncologist· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes of bevacizumab beyond progression in metastatic colorectal cancer patients treated in US community oncology.
Thomas H Cartwright, Yeun Mi Yim, Elaine Yu, Hsingwen Chung, Melissa Halm

Clin Colorectal Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
Aimery de Gramont, Eric Van Cutsem, Hans-Joachim Schmoll, Josep Tabernero, Stephen Clarke, Thomas H Cartwright

Lancet Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment decisions after diagnosis of metastatic colorectal cancer.
Thomas H Cartwright

Clin Colorectal Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a performance improvement initiative in colorectal cancer care.
John L Marshall, Thomas H Cartwright, Carolyn A Berry, Stephanie A Stowell, Sara C Miller

J Oncol Pract· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial.
Paul B Jacobsen, Kristen J Wells, Cathy D Meade, Gwendolyn P Quinn, Ji-Hyun Lee, Thomas H Cartwright

J Clin Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer Care.
Erin M Siegel, Paul B Jacobsen, Mokenge Malafa, William Fulp, Michelle Fletcher, Thomas Cartwright

J Oncol Pract· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in Florida.
Tawee Tanvetyanon, Michelle Corman, Ji-Hyun Lee, William J Fulp, Fred Schreiber, Thomas H Cartwright

J Oncol Pract· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degree of variability in performance on breast cancer quality indicators: findings from the Florida initiative for quality cancer care.
Jhanelle E Gray, Christine Laronga, Erin M Siegel, Ji-Hyun Lee, William J Fulp, Thomas Cartwright

J Oncol Pract· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databases.
J Russell Hoverman, Thomas H Cartwright, Debra A Patt, Janet L Espirito, Matthew P Clayton

Am J Manag Care· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.
J Russell Hoverman, Thomas H Cartwright, Debra A Patt, Janet L Espirito, Matthew P Clayton

J Oncol Pract· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison.
Edward Chu, Kathy L Schulman, Edward F McKenna, Thomas Cartwright

Clin Colorectal Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis